Nucleic acid immunization: Concepts and techniques associated with third generation vaccines

Journal of Immunological Methods

Volumn 229, Issue 1-2, 1999, Pages 1-22

  Hasan, U A ^a   M Abai, A ^b   Harper, D R ^a   Wren, B W ^a   Morrow, W J W ^a  

^a Molec Immunol Infect Res Grp   (United Kingdom)

^b VICAL INC   (United States)

Author keywords

Delivery systems; DNA vaccines; Genetic immunization; Naked DNA; Nucleic acid immunization

Indexed keywords

DNA VACCINE; PLASMID DNA;

ACTIVE IMMUNIZATION; DNA TRANSFECTION; DRUG DELIVERY SYSTEM; EXPRESSION VECTOR; GENE GUN; HUMAN; IMMUNE SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CLINICAL TRIALS; GENETIC VECTORS; HUMANS; IMMUNIZATION; PROMOTER REGIONS (GENETICS); T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA;

EID: 0032722995     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(99)00104-0     Document Type: Review

References (144)

1. Agadjanyan M.G., Wang B., Nyland S.B., Weiner D.B., Ugen K.E. DNA plasmid based vaccination against the oncogenic human T cell leukemia virus type 1. Curr. Top. Microbiol Immunol. 226:1998;175.
2. Alves A.M., Lasato M.O., Almeida D.F., Ferreira L.C. Epitope specificity of antibodies raised against enterotoxigenic Escherichia coli CFA/I fimbriae in mice immunized with naked DNA. Vaccine. 16:1998;9.
3. Anderson R., Gao X.M., Papakonstantinopoulou A., Fairweather N., Roberts M., Dougan G. Immunization of mice with DNA encoding fragment C of tetanus toxin. Vaccine. 15:1997;827.
4. Andre S., Seed B., Eberle J., Schraut W., Bultmann A., Haas J. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J. Virol. 72:1998;1497.
5. Antohi S., Bot A., Manfield L., Bona C. The reactivity pattern of hemagglutinin-specific clonotypes from mice immunized as neonates or adults with naked DNA. Int. Immunol. 10:1998;663.
6. Ashley D.M., Faiola B., Nair S., Laura P.H., Bigner D.D., Gilboa E. Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induced antitumor immunity against central nervous system tumors. J. Exp. Med. 186:1997;1177.
7. Atanasiu P. Production de tumers chez le hamster par inoculation d'acide desoxyribonucleique extrait de cultures des tissues infectees par le virus de polyome. Acad. Sci. 254:1962;4228.
8. Ayyavoo V., Nagashunmugam T., Phung M.T., Buckner C., Kudckodkar S., Le P., Reddy P.J., Santiago L., Patel M., Tea L., Weiner D.B. Construction of attenuated HIV-1 accessory gene immunization cassettes. Vaccine. 16:1998;1872.
9. Barry M.A., Barry M.E., Johnston S.A. Production of monoclonal antibodies by genetic immunization. BioTechniques. 16:1994;616.
10. Barry M.A., Lai W.C., Johnston S.A. Protection against mycoplasma infection using expression library immunization. Nature. 377:1995;632.
11. Bonato V.L.D., Lima V.M.F., Tascon R.E., Lowrie D.B., Silva C.L. Identification and characterization of protective T cells in hsp65 DNA vaccinated and Mycobacterium tuberculosis infected mice. Infect. Immun. 66:1998;169.
12. Boyer J.D., Ugen K.E., Wang B., Agadjanyan M., Gilbert L., Bagarazzi M.L., Chattergoon M., Frost P., Javadian A., Williams W.V., Refaeli Y., Ciccarelli R.B., McCallus D., Coney L., Weiner D.B. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nature Medicine. 3:1997;526.
13. Bueler H., Mulligan R.C. Induction of antigen specific tumor immunity by genetic and cellular vaccines against MAGE: enhanced tumor protection by co-expression of granulocyte-macrophage colony stimulating factor and B7-1. Mol. Med. 5:1996;545.
14. Calarota S., Bratt G., Nordlund S., Hinkula J., Leandersson A.C., Sandstrom E., Wahren B. Cellular cytotoxic responses induced by DNA vaccination in HIV-1 infected patients. Lancet. 351:1998;1320.
15. Cardoso A.I., Sixt N., Vallier A., Fayolle J., Buckland R., Wild T.F. Measles virus DNA vaccination: antibody isotype is determined by the method of immunization and by the nature of both the antigen and the coimmunized antigen. J. Virol. 72:1998;2516.
16. Carson D.A., Raz E. Oligonucleotide adjuvants for T helper 1 (Th1)-specific vaccination. J. Exp. Med. 186:1997;1621.
17. Chen Y., Hu D., Eling D.J., Robbins J., Kipps T.J. DNA vaccines encoding full-length or truncated Neu induce protective immunity against Neu-expressing mammary tumors. Cancer Res. 58:1998;1965.
18. Chen Y., Webster R.G., Woodland D.L. Induction of CD8+ T cell responses to dominant and subdominant epitopes and protective immunity to Sendai virus infection by DNA vaccination. J. Immunol. 160:1998;2425.
19. Chinsangaram J., Beard C., Mason P.W., Zellner M.K., Ward G., Grubman M.J. Antibody response in mice inoculated with DNA expressing foot and mouth disease virus capsid proteins. J. Virol. 72:1998;4454.
20. Chow Y.H., Chiang B.L., Lee Y.L., Chi W.K., Lin W.C., Chen Y.T., Tao M.H. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J. Immunol. 160:1998;1320.
21. Chu R.S., Targoni O.S., Krieg A.M., Lehmann P.V., Harding C.V. CpG Oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186:1997;1623.
22. Ciernik I.F., Berzofsky J.A., Carbone D.P. Induction of cytotoxic lymphocytes and antitumor immunity with DNA vaccines expressing single T cell epitopes. J. Immunol. 156:1996;2369.
23. Concetti A., Amici A., Petrelli C., Tibaldi A., Provinciali M., Venanzi F.M. Autoantibody to p185erbB2/neu oncoprotein by vaccination with xenogenic DNA. Cancer Immunol. Immunother. 43:1996;307.
24. Corr M., Lee J.D., Carson D.A., Tighe H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 184:1996;1555.
25. Cox G.J., Zamb T.J., Babiuk L.A. Bovine herpes virus 1: immune response in mice and cattle injected with plasmid DNA. J. Virol. 67:1993;5664.
26. Czerkinsky C., Quiding M., Eriksson K., Nordstrom I., Lakew M., Weneras C., Kilander A., Bjorck S., Svennerholm A.M., Butcher E. Induction of specific immunity at mucosal surfaces: prospects for vaccine development. Adv. Exp. Med. Biol. 371B:1995;1409.
27. Darji A., Guzman A., Getstel B., Wacholz P., Timmis K.N., Wehland J., Chakraborty T., Weiss S. Oral somatic transgene vaccination using attenuated S. tyhpimurium. Cell. 91:1997;617.
28. Davis H.L., Weeratna R., Waldschmidt T.J., Tygrett L., Schorr J., Krieg A.M. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160:1998;870.
29. Davis H.L., Whalen R.G., Demeniex B.A. Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther. 4:1993;151.
30. Davis H.L., Michel M.L., Whalen R.G. Use of plasmid DNA for direct gene transfer and immunization. Ann. N. Y. Acad. Sci. 772:1995;21.
31. de Zoten E.F., Carr-Brendel V., Cohen E.P. Resistance to melanoma in mice immunized with semiallogeneic fibroblasts transfected with DNA from mouse melanoma cells. J. Immunol. 160:1998;2915.
32. Dietrich G., Bubert A., Gentschev I., Sokolovic Z., Simm A., Catic A., Kaufmann S.H.E., Hess J., Szalay A., Goebel W. Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attentuated suicide Listeria monocytogenes. Nature Biotechnology. 16:1998;181.
33. Dixon B. The third vaccine revolution. Bio/Technology. 13:1995;420.
34. Donnelly J.J., Friedman A., Martinez D., Montgomery D.L., Shiver J.W., Motzel S.L., Ulmer J.B., Liu M.A. Preclinical efficiacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nature Medicine. 1:1995;583.
35. Donnelly J.J., Martinez D., Jansen K.U., Ellis R.W., Montgomery D.L., Liu M.A. Protection against papillomavirus with a polynucleotide vaccine. J. Infect. Dis. 173:1996;314.
36. Doolan D.L., Sedegah D., Hedstrom R.C., Hobart P., Charoenvit Y., Hoffman S.L. Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell, interferon gamma and nitric oxide dependent immunity. J. Exp. Med. 183:1996;1739.
37. Dummer R., Davis-Daneshfat A., Dohring C., Dobbeling U., Burg G. Strategies for gene therapy of melanoma. Hautarzt. 46:1995;305.
38. Encke J., zu Putlitz J., Geissler M., Wands J.R. Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model. J. Immunol. 161:1998;4917.
39. Ertl H.C.J., Xiang Z.Q. Genetic immunization. Viral Immunol. 9:1996;1.
40. Feltquate D.M., Heaney S., Webster R.G., Robinson H.L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158:1997;2278.
41. Forg P., Hoegen P., Dalesmans W., Schirrmacher V. Superiority of the ear pinna over muscle tissue as a site for DNA vaccination. Gene Ther. 5:1998;789.
42. Fried M., Klein B., Murray K., Greenaway P., Tooze J., Boll W., Weissmann C. Infectivity in mouse fibroblasts of polyoma DNA integrated into plasmid pBR322 or lambdoid phage DNA. Nature. 279:1979;811.
43. Fu T.M., Friedman A., Ulmer J.B., Liu M.A., Donnelly J.J. Protective cellular immunity: cytotoxic T lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization. J. Virol. 71:1997;2715.
44. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., Robinson H.L. DNA vaccines: protective immunizations by parenteal, mucosal, and gene gun inoculations. Proc. Natl. Acad. Sci. U.S.A. 90:1993;11478.
45. Fynan E.F., Webster R., Fuller D.H., Haynes J.R., Santoro J.C., Robinson H.L. DNA vaccines: a novel approach to immunization. Int. J. Immunopharmacol. 17:1995;79.
46. Geddes B.J., Harding T.C., Lightman S.L., Uney J.B. Long-term gene therapy in the CNS: reversal by hypothalamic diabetes insipidus in the Brattlebro rat by using an adenovirus expressing arginine vasopressin. Nature Medicine. 3:1997;1402.
47. Gregoriadis G., Saffie R., De Souza J.B. Liposome mediated DNA vaccination. FEBS Letters. 402:1997;107.
48. Gurunathan S., Sacks D.L., Brown D.R., Reiner S.L., Chatert H., Glaichenhaus N., Seder R.A. Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. J. Exp. Med. 186:1997;1137.
49. Hakim I., Levy S., Levy R. A nine-amino acid peptide from IL-1beta augments antitumor immune responses induced by protein DNA vaccines. J. Immunol. 157:1996;5503.
50. Hamajima K., Sasaki S., Fukushima J., Kaneko T., Xin K.Q., Kudoh I., Okuda S., Okuda K. Intranasal administration of HIV-DNA Vaccine formulated with a polymer, carboxymethylcellulose, augments mucosal antibody production and cell-mediated immune response. Clin. Immunol. Immunopathol. 882:1998;205.
51. Hanke T., Blanchard T.J., Schneider J., Hannan C.M., Becker M., Gilbert S.C., Hill A.V.S., Smith G.L., McMichael A. Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime. Vaccine. 16:1998;439.
52. Harms J.S., Splitter G.A. Interferon gamma inhibits transgene expression driven by SV-40 or CMV promoters but augments expression driven by the mammalian MHC I promoter. Hum. Gene Ther. 6:1995;1291.
53. Harpin S., Talbot B., Mbikay M., Elazhary Y. Immune response to vaccination with DNA encoding the bovine viral diarrhea virus major glycoprotein gp53 (E2). FEMS Microbiol. Lett. 146:1997;229.
54. Hartikka J., Sawdey M., Cornefert-Jensen F., Margalith M., Barnhart K., Nolasco M., Wahlsing M., Meek J., Marquet M., Hobart P., Norman J., Manthorpe M. An improved plasmid DNA expression vector for direct injection into skeletal muscle. Hum. Gene Ther. 7:1996;1205.
55. Hasan U.A., Rajananthanan P., Harper D.R., Tregaskis R.J., Sheikh N., Wren B.W., Layton G., Morrow W.J.W. Construction and immunization of DNA expression vector encoding the varicella zoster virus glycoprotein E (gE) gene. Immunology. 92:1997;56. Suppl. 1.
56. Hathaway L.J., Partidos C.D., Vohra P., Steward M.W. Induction of immune responses to measles virus synthetic peptides administered intranasally. Vaccine. 13:1995;1495.
57. Hawkins R.E., Winter G., Hamblin T.J., Stevenson F.K., Russell S.J. A genetic approach to idiotypic vaccination. J. Immunother. 14:1993;273.
58. Hawkins R.E., Russell S.J., Marcus R., Ashworth L.J., Brissnik J., Zhang J., Winter G., Bleehen N.M., Shaw M.M., Williamson L., Ouwehand W., Stevenson F., Hamblin T., Oscier D., Zhu D., King C., Kumar S., Thompsett A., Stevenson G.T. A pilot study of idiotypic vaccination for follicular B-cell lymphoma using a genetic approach. Hum. Gene Ther. 8:1997;1287.
59. Healy B. Mucosal immunity, vaccine development's new frontier. Am. Med. Assoc. 269:1990;1612.
60. Ho T.Y., Hsiang C.Y., Hsiang C.H., Chang T.J. DNA vaccination induces a long term antibody response and protective immunity against pseudorabies virus in mice. Arch. Virol. 143:1998;115.
61. Horn N., Meek J., Budahazi G., Marquet M. Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials. Hum. Gene Ther. 6:1995;565.
62. Horspool J.H., Perrin P.J., Woodcock J.B., Cox J.H., King C.L., June C.H., Harlan D.M., St.Louis D.C., Lee K.P. Nucleic acid vaccine induced immune responses require CD28 costimulation and are regulated by CTLA4. J. Immunol. 160:1998;2706.
63. Hsu C.H., Chua K.Y., Tao M.H., Huang S.K., Hsieh K.H. Inhibition of specific IgE response in vivo by allergen gene transfer. Int. Immunol. 8:1996;1405.
64. Ito Y. A tumor reducing factor extracted by phenol from papillomatous tissue of cottontail rabbits. Virology. 12:1960;596.
65. Johnston S.A., Barry M.A. Genetic to genomic vaccination. Vaccine. 15:1997;808.
66. Klinman D.M., Yamschchikov G., Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 158:1997;3635.
67. Klinman D.M., Sechler J.M.G., Conover J., Gu M., Rosenberg A.S. Contribution of cells at the site of DNA vaccination to the generation of antigen specific immunity and memory. J. Immunol. 160:1998;2388.
68. Koltover I., Salditt T., Radler J.O., Safinya C.R. An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. Science. 281:1998;78.
69. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Tiesdale R., Koretzky G.A., Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:1995;546.
70. Kriesel J.D., Spruance S.L., Daynes R.A., Araneo B.A. Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease. J. Infect. Dis. 173:1996;536.
71. Kuklin N., Daheshia M., Karem K., Manickan E., Rouse B.T. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J. Virol. 71:1997;3138.
72. Larsen D.L., Dybdahl-Sissoko N., McGregor M.W., Drape R., Neumann V., Swain W.F., Lunn D.P., Olsen C.W. Coadministration of DNA encoding interleukin-6 and hemagglutinin confers protection from influenza virus challenge in mice. J. Virol. 72:1998;1704.
73. Lee S.W., Cho J.H., Sung Y.C. Optimal induction of hepatitis C virus envelope-specific immunity by bicistronic plasmid DNA inoculation with the granulocyte-macrophage colony-stimulating factor gene. J. Virol. 72:1998;8430.
74. Leitner W.W., Seguin M.C., Ballou W.R., Seitz J.P., Schultz A.M., Sheehy M.J., Lyon J.A. Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites. J. Immunol. 159:1997;6112.
75. Letvin N.L., Montetiori D.C., Yasutomi Y., Perry H.C., Davies M.E., Lekutis C., Alroy M., Freed D.C., Lord C.I., Handt L.K., Liu M.A., Shiver J.W. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc. Natl. Acad. Sci. U.S.A. 94:1997;9378.
76. Liang X., Hartikka J., Sukhu L., Manthorpe M., Hobart P. Novel, high expressing and antibiotic controlled plasmid vectors designed for use in gene therapy. Gene Ther. 3:1996;350.
77. Liu M.A., McClements W., Ulmer J.B., Shiver J., Donnelly J. Immunization of non-human primates with DNA vaccines. Vaccine. 15:1997;909.
78. Livingston J.B., Lu S., Robinson H., Anderson D.J. Immunization of the female genital tract with a DNA based vaccine. Infect. Immun. 66:1998;322.
79. Lobell A., Weissert R., Storch M.K., Svanholm C., de Graat K.L., Lassmann H., Andersson R., Olsson T., Wigzell H. Vaccination with DNA encoding the immunodominant myelin basic protein peptide targeted to Fc of immunoglobulin G suppresses experimental autoimmune encephalomyelitis. J. Exp. Med. 187:1998;1543.
80. Lu S., Arthos J., Monteriori D.C., Yasutomi Y., Manson F., Mustafa F., Johnson E., Santoro J.C., Wissink J., Mullins J.I., Haynes J.R., Letvin N.L., Wyand M., Robinson H.L. Simian immunodeficiency virus DNA vaccine trial in macaques. J. Virol. 70:1996;3978.
81. Luke C.J., Carner K., Liang X., Barbour A.G. An OspA based DNA vaccine protects mice against infection with Borrelia burgdorferi. J. Infect. Dis. 175:1997;91.
82. Macklin M.D., McCabe D., McGregor M.W., Neumann V., Meyer T., Callan R., Hinshaw V.S., Swain W.F. Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challange with homologous virus. J. Virol. 72:1998;1491.
83. Manickan E., Kanangat S., Rouse R.J., Yu Z., Rouse B.T. Enhancement of the immune response to naked DNA vaccine by immunization with transfected dendritic cells. J. Leukocyte Biol. 61:1997;125.
84. Mason H.S., Ball J.M., Shi J.J., Jiang X., Estes M.K., Arntzen C.J. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc. Natl. Acad. Sci. U.S.A. 93:1996;5335.
85. Mendoza R.B., Cantwell M.J., Kipps T.J. Immunostimulatory effects of a plasmid expressing CD40 ligand (CD154) on gene immunization. J. Immunol. 159:1997;5777.
86. Mor G., Singla M., Steinberg A.D., Hoffman S.L., Okuda K., Klinman D.M. Do DNA vaccines induce autoimmune disease. Hum. Gene Ther. 8:1997;293.
87. Manoutcharian K., Terrazas L.I., Gevorkian G., Govezensky T. Protection against murine cysticercosis using cDNA expression library immunization. Immunol. Lett. 62:1998;131.
88. Nass P.H., Elkins K.L., Weir J.P. Antibody response and protective capacity of plasmid vaccines expressing three different herpes simplex virus glycoproteins. Infect. Dis. 178:1998;611.
89. Nichols W.W., Ledwith B.J., Manam S.V., Troilo P.J. Potential DNA vaccine integration into host cell genome. Ann. N. Y. Acad. Sci. 772:1995;30.
90. Norman J.A., Hobart P., Manthorpe M., Felgner P., Wheeler C. Development of improved vectors for DNA-based immunization and other gene therapy applications. Vaccine. 15:1997;801.
91. Okuda K., Bukawa H., Hamajima H., Kawamoto S., Sekigawa K., Yamada Y., Tanaka S., Ishi N., Aoki I., Nakamura M. Induction of potent humoral and cell mediated immune responses following injection of DNA encoding the HIV type 1 env and rev gene products. AIDS Res. Hum. Retrovirus. 11:1995;933.
92. Osterrieder N., Wagner R., Brandmuller C., Schmidt P., Wolf H., Kaaden O.R. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB). Virology. 208:1995;500.
93. Pande H., Campo K., Tanamachi B., Forman S.J., Zaia J.A. Direct DNA immunization of mice with plasmid DNA encoding the tegument protein pp65 (ppUL83) of human cytomegalovirus induces high levels of circulating antibody to the encoded protein. Scand. J. Infect. Dis., Suppl. 99:1995;117.
94. Pertmer T.M., Roberts T.R., Haynes J.R. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virology. 70:1996;6119.
95. Qin L., Ding Y., Pahud D.R., Chang E., Imperiale M.J., Bromberg S. Promoter attenuation in gene therapy: interferon gamma and tumor necrosis factor alpha inhibit transgene expression. Hum. Gene Ther. 8:1996;2019.
96. Ragno S., Colston M.J., Lowrie D.B., Winrow V.R., Blake D.R., Tascon R. Protection of rats from adjuvant arthritis by immunization with naked DNA encoding for mycobacterial heat shock protein 65. Arthritis Rheum. 40:1997;277.
97. Rakhmilevich A.J., Turner J., Ford M.J., McCabe D., Sun W.H., Sondel P.M., Grota K., Yang N.S. Gene gun mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumours. Proc. Natl. Acad. Sci. U.S.A. 93:1996;6291.
98. Raychaudhuti S., Morrow W.J.W. Can soluble antigens induce class I-restriced immune responses. A paradox revisited. Immunol. Today. 14:1993;344.
99. Raz E., Carson D.A., Parker S., Parr T.B., Abai A.M., Aichinger G., Gromkowski S.H., Singh M., Lew D., Yankauckas M.A., Baird S.M., Rhodes G.H. Indradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. U.S.A. 91:1994;9519.
100. Raz E., Dudler J., Lotz M., Baird S.M., Berry C.C., Eisenberg R.A., Carson D.A. Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery. Lupus. 4:1995;286.
101. Rhodes G.H., Abai A.M., Margalith M., Kuwahara-Rundell A., Morrow J., Parker S.E., Dwarki V.J. Characterization of humoral immunity after DNA injection. Dev. Biol. Stand. 82:1994;229.
102. Richardson J., Moraillon A., Baud S., Cuisinier A.M., Sonigo P., Pancino G. Enhancement of Feline Immunodeficiency Virus (FIV) infection after DNA vaccination with the FIV envelope. J. Virol. 71:1997;9640.
103. Rodriguez F., Zhang J., Whitton J.L. DNA immunization: ubiquitination of a viral protein enhances cytotoxic T lymphocyte induction and antiviral protection but abrogates antibody induction. J. Virol. 71:1997;8497.
104. Rosas G., Cruz-Revilla C., Fragoso G., Lopez-Casillas F., Perez A., Bonilla M.A., Rosales R., Sciutto E. Taenia crassiceps cysticercosis: humoral immune response and protection elicited by DNA immunization. J. Parasitol. 84:1998;516.
105. Roy K., Mao H.Q., Huang S.K., Leong K.W. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nature Medicine. 5:1999;387.
106. Sakaguchi M., Nakamura H., Sonoda K., Hamada F., Hirai K. Protection of chickens from Newcastle disease by vaccination with a linear plasmid DNA expressing the F protein of Newcastle disease virus. Vaccine. 14:1996;747.
107. Sasaki S., Tsuji T., Hamajima K., Fukushima J., Ishii N., Kaneko T., Xin K.Q., Mohri H., Aoki I., Okubo T., Nishioka K., Okuda K. Monophosphoryl lipid A enhances both humoral and cell mediated immune responses to DNA vaccination agaist human immunodeficiency virus type 1. Infect. Immun. 65:1997;3520.
108. Sasaki S., Fukushima J., Hamajima K., Ishii N., Tsuji T., Xin K.Q., Mohri H., Okuda K. Adjuvant effect of ubenimex on a DNA vaccine for HIV-1. Clin. Exp. Immunol. 111:1998;30.
109. Sasaki S., Hamajima K., Fukushima J., Ihata A., Ishii N., Gorai I., Hirahara F., Mohri H., Okuda K. Comparison of intranasal and intramuscular immunization against Human Immunodeficiency Virus type 1 with a DNA monophosphoryl lipid A adjuvant vaccine. Infect. Immun. 66:1998;823.
110. Sasaki S., Sumino K., Hamajima K., Fukushima J., Ishii N., Kawamoto S., Mohri H., Kensil C.R., Okuda K. Induction of systemic and mucosal responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes. J. Virol. 72:1998;4931.
111. Sato Y., Roman M., Tighe H., Lee D., Corr M., Nguyen M.D., Silverman G.J., Lotz M., Carson D.A., Raz E. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science. 273:1996;352.
112. Schirmbeck R., Bohm W., Reimann J. DNA vaccination primes MHC class I restricted, simian virus 40 large tumor antigen-specific CTL in H-2d mice that reject syngeneic tumors. J. Immunol. 157:1996;3550.
113. Schmaljohn C., Vanderzanden L., Bray M., Custer D., Meyer B., Li D., Rossi C., Fuller D., Fuller J., Haynes J., Huggins J. Naked DNA vaccines expressing the prM and E genes of Russian Spring Summer Encephalitis virus and central european Encephalitis virus protects mice from homologous and heterologous challenge. J. Virol. 71:1997;9563.
114. Schneider J., Gilbert S.C., Blanchard T.J., Hanke T., Robson K.J., Hannan C.M., Becker M., Sinden R., Smith G., Hill A.V.S. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccina virus Ankara. Nature Medicine. 4:1998;397.
115. Sheikh N., Rajananthanan P., Morrow W.J.W. Immunological adjuvants: mechanisms of action and clinical applications. Exp. Opin. Invest. Drugs. 5:1996;1079.
116. Shimada S., Yano O., Tokunaga T. In vivo augmentation of natural killer cell activity with a deoxyribonucleic acid fraction of BCG. Jpn. J. Cancer Res. 77:1986;808.
117. Shiver J.W., Perry H.C., Davies M.E., Freed D.C., Liu M.A. Cytotoxic T lymphocyte and helper T cell responses following HIV polynucleotide vaccination. Ann. N. Y. Acad. Sci. 772:1995;198.
118. Sizemore D.R., Branstrom A.A., Sadoff J.C. Attenuated Shigella as a DNA delievery vehicle for DNA-mediated immunization. Science. 270:1995;299.
119. Sizemore D.R., Branstrom A.A., Sadoff J.C. Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization. Vaccine. 15:1997;804.
120. Sparwasser T., Koch E.S., Vabulas R.M., Heeg K., Lipford G.B., Ellwart J.W., Wagner H. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28:1998;2045.
121. Sudo T., Makiguchi N., Suganuma T. Antitumor activity of deoxyribonucleic acid fraction from mycobacterium bovis GCC: I. Isolation physicochemical characterization and antitumor activity. J. Natl. Cancer Inst. 72:1984;955.
122. Sun S., Kishimoto H., Sprent J. DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen. J. Exp. Med. 187:1998;1145.
123. Tacket C.O., Mason H.S., Losonsky G., Clements J.D., Levine M.M., Arntzen C.J. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nature Medicine. 4:1998;607.
124. Tan J., Newton C.A., Djeu J.Y., Gutsch D.E., Chang A.E., Yang N.S., Klein T.W., Hua Y. Injection of a complementary DNA encoding interleukin-12 inhibits tumor establishment at a distant site in a murine renal carcinoma model. Cancer Res. 56:1996;3399.
125. Tang D.C., DeVit M., Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature. 356:1992;152.
126. Tascon R.E., Colston M.J., Ragno S., Stavropoulos E., Gregory D., Lowrie D.B. Vaccination against tuberculosis by DNA injection. Nature Medicine. 2:1996;888.
127. Triyatni M., Jilbert A.R., Qiao M., Miller D.S., Burrell C.J. Protective efficacy of DNA vaccines against duck hepatitis B virus infection. J. Virol. 72:1998;84.
128. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., DeWitt C.M., Friedman A. Heterologous protection against influenza by injection of DNA encoding viral protein. Science. 259:1993;1745.
129. Ulmer J.B., Deck R.R., DeWitt C.M., Friedman A., Donnelly H.H., Liu M.A. Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine. 12:1994;1541.
130. Walker P.S., Scharton-Kersten T., Rowton E.D., Hengge U., Bouloc A., Udey M.C., Vogel J.C. Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis. Hum. Gene Ther. 9:1998;1899.
131. Wang R., Doolan D.L., Thonge T.P., Hedstrom R.C., Coonan K.M., Charoenvit Y., Jones T.R., Hobart P., Margalith M., Ng J., Weiss W.R., Sedegah M., de Taisne C., Norman J.A., Hoffman S.L. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science. 282:1998;476.
132. Ward G., Rieder E., Mason P.W. Plasmid DNA encoding replicating foot and mouth disease virus genomes induces antiviral immune resposes in swine. J. Virol. 71:1997;7442.
133. Whalen R.G., Leclerc E., Deriaud R., Schirmbeck J., Reimann J., Davis H.L. DNA mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response. Ann. N. Y. Acad. Sci. 772:1995;64.
134. Wizel B., Garg N., Tarleton R.L. Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection. Infect. Immun. 66:1998;5073.
135. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., Felgner P.L. Direct gene transfer into mouse muscle in vivo. Science. 247:1990;1465.
136. Wu Y., Kipps T.J. Deoxyribonucleic acid vaccines encoding antigens with rapid proteasome-dependent degradation are highly efficient inducers of cytolytic lymphocytes. J. Immunol. 159:1997;6037.
137. Xiang Z.Q., Spitalnik S.L., Cheng J., Erikson J., Wojczyk B., Ertl H.C. Immune responses to nucleic acid vaccines to rabies. Virology. 209:1995;569.
138. Xu D., Liew F.Y. Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major. Immunology. 84:1995;173.
139. Yamamoto S., Yamamoto T., Kataoka T., Kuramoto E., Yano O., Tokunaga T. Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J. Immunol. 148:1992;4072.
140. Yang N.S., Burkholder J., Roberts B., Martinell B., McCabe D. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc. Natl. Acad. Sci. U.S.A. 87:1990;9568.
141. Yang W., Waine G.J., MacManus D.P. Antibodies to Schistosoma japonicum (Asian blood fluke) paramyosin induced by nucleic acid vaccination. Biochem. Biohys. Res. Commun. 212:1995;1029.
142. Yankauckas M.A., Morrow J.E., Parker S.E., Abai A., Rhodes G.H., Dwarki V.J., Gromkowski S.H. Long-term anti-nucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid DNA containing NP gene. DNA Cell Biol. 12:1993;771.
143. Zarozinski C.C., Fynan E., Selin L.K., Robinson H.L., Welsh R.M. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J. Immunol. 154:1995;4010.
144. Zhu X., Venkataprasad N., Thangaraj H.S., Hill M., Singh M., Ivanyi J., Vordermeier H.M. Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. J. Immunol. 158:1997;5921.